FDA — authorised 30 August 2018
- Application: NDA210807
- Marketing authorisation holder: MSD MERCK CO
- Local brand name: DELSTRIGO
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Doravirine + tenofovir DF + lamivudine in United States
FDA authorised Doravirine + tenofovir DF + lamivudine on 30 August 2018
Marketing authorisation
Other Infectious Disease / Virology approved in United States
Frequently asked questions
Is Doravirine + tenofovir DF + lamivudine approved in United States?
Yes. FDA authorised it on 30 August 2018.
Who is the marketing authorisation holder for Doravirine + tenofovir DF + lamivudine in United States?
MSD MERCK CO holds the US marketing authorisation.